Insmed (INSM) Change in Receivables (2010 - 2026)
Insmed (INSM) recorded quarterly Change in Receivables of $38.2 million in Q1 2026, down 50.6% quarter-over-quarter from $77.3 million in Q4 2025, and up 812.37% on a YoY basis from $4.2 million in Q1 2025.
Insmed (INSM) Change in Receivables (2010 - 2026) Analysis & Trends
Insmed's Change in Receivables history runs 12 years deep, the most recent figure standing at $38.2 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 812.37% year-over-year to $38.2 million; the TTM figure through Mar 2026 stood at $131.9 million (up 1152.69% YoY), while the FY2025 annual figure was $88.3 million, up 582.86% from the prior year.
- Change in Receivables was $38.2 million for Q1 2026 at Insmed, down from $77.3 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $77.3 million in Q4 2025 to a low of -$5.4 million in Q1 2025.
- Historically, Change in Receivables has averaged $9.3 million across 5 years, with a median of $4.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables tumbled 443.6% in 2024, then jumped 29117.14% in 2025.
- A 5-year view of Change in Receivables shows it stood at $983000.0 in 2022, then soared by 361.34% to $4.5 million in 2023, then jumped by 160.57% to $11.8 million in 2024, then jumped by 554.14% to $77.3 million in 2025, then sank by 50.6% to $38.2 million in 2026.
- The last three Change in Receivables figures came in at $38.2 million (Q1 2026), $77.3 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -4.08 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 38.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.19 Mn |
| Mar 31, 2026 | 38.19 Mn |
| Dec 31, 2025 | 77.30 Mn |
| Dec 31, 2025 | 77.30 Mn |
| Sep 30, 2025 | 10.23 Mn |
| Sep 30, 2025 | 10.23 Mn |
| Jun 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 6.14 Mn |
| Mar 31, 2025 | -5.36 Mn |
| Mar 31, 2025 | -5.36 Mn |
| Dec 31, 2024 | 11.82 Mn |
| Dec 31, 2024 | 11.82 Mn |
| Sep 30, 2024 | 35,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 4.04 Mn |
| Jun 30, 2024 | 4.04 Mn |
| Mar 31, 2024 | -2.96 Mn |
| Mar 31, 2024 | -2.96 Mn |
| Dec 31, 2023 | 4.54 Mn |
| Dec 31, 2023 | 4.54 Mn |